ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer, Allogene link to develop cancer therapies
July 18, 2018Pfizer and Allogene have entered into an agreement to develop allogeneic CAR T cell therapies. -
Pfizer and Allogene Therapeutics enter into asset contribution agreement for Pfizer's allogeneic CAR T immuno-oncology portfolio
April 09, 2018Pfizer Inc today announced that the two companies have entered into an asset contribution agreement for Pfizer's portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR T) therapy -
Proposed guidelines for handling CAR T cell side effects
September 21, 2017Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists… -
Takeda partners up to develop "next generation" CAR T solid tumour therapy
September 05, 2017Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR T) therapy for effectively treating solid tumours, it has emerged. -
FDA approves CAR T cell therapy for children with leukaemia
September 01, 2017The FDA has approved CAR T cell therapy for treatment of children with acute lymphoblastic leukemia… -
FDA approves CAR T cell therapy for kids with leukemia
September 01, 2017St. Baldrick's Foundation plays a key role in bringing this therapy to reality. -
New research claims first response of nervous system tumour to CAR T therapy
August 30, 2017Researchers at a General Hospital in Massachusetts has claimed first-ever response of a nervous system tumour to CAR T cancer therapy.
Pharma Sources Insight January 2025
